» Authors » Vahram H Ghushchyan

Vahram H Ghushchyan

Explore the profile of Vahram H Ghushchyan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 444
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan P, Ghushchyan V, Skoner D, Lecocq J, Park S, Zeiger R
J Allergy Clin Immunol Pract . 2020 Dec; 9(4):1541-1551.e9. PMID: 33290914
Background: Limited comparative data are available on the impact of systemic corticosteroid (SCS) use in children and adolescents. Objective: To determine if asthmatic children and adolescents treated with SCS have...
2.
Sullivan P, Kavati A, Ghushchyan V, Lanz M, Ortiz B, Maselli D, et al.
J Asthma . 2019 Jul; 57(11):1263-1272. PMID: 31311356
To estimate the health-related quality of life (HRQoL) and health utilities among asthma patients with and without comorbid allergies in a managed care population. This was a retrospective analysis of...
3.
Sullivan P, Lanz M, Ghushchyan V, Kavati A, Lecocq J, Ortiz B, et al.
J Asthma . 2019 Jul; 57(9):959-967. PMID: 31264894
To compare healthcare resource utilization (HCRU), healthcare expenditures, and work productivity and activity impairment within a general asthma population with persistent asthma and evidence of allergy (PA-EA) and persistent asthma...
4.
Sullivan P, Lanz M, Ghushchyan V, Kavati A, Lecocq J, Ortiz B, et al.
Allergy Asthma Proc . 2019 May; 40(4):221-229. PMID: 31053178
Approximately two-thirds of people with asthma have some evidence of allergy; their condition differs from nonallergic asthma in terms of predominant symptoms and clinical outcomes. To compare asthma control and...
5.
Sullivan P, Ghushchyan V, Marvel J, Barrett Y, Fuhlbrigge A
J Allergy Clin Immunol Pract . 2019 Apr; 7(7):2319-2325. PMID: 31034996
Background: FEV as a percentage of predicted (FEV%pred) is commonly measured in asthma clinical studies; however, reports vary on its association with asthma control instruments evaluating symptoms. Objective: Assess the...
6.
Sullivan P, Ghushchyan V, Globe G
J Asthma . 2017 Oct; 55(9):1002-1010. PMID: 28976789
Background: Asthma control is the main focus of treatment guidelines. Valid instruments such as the Asthma Control Questionnaire (ACQ) require prospective survey. These surveys may be challenging for large population...
7.
Sullivan P, Ghushchyan V, Globe G, Schatz M
J Allergy Clin Immunol . 2017 May; 141(1):110-116.e7. PMID: 28456623
Background: Significant adverse effects (AEs) have been associated with continuous exposure to oral corticosteroids (OCSs). The potential association with intermittent exposure is unknown. Objective: We sought to assess the association...
8.
Sullivan P, Ghushchyan V
Value Health . 2016 Dec; 19(8):1002-1008. PMID: 27987626
Background: A single-source catalogue of nationally representative EuroQol five-dimensional questionnaire (EQ-5D) scores for chronic conditions in the United States and the United Kingdom from the Medical Expenditure Panel Survey (MEPS)...
9.
Sullivan P, Ghushchyan V, Globe G, Sucher B
Qual Life Res . 2016 Oct; 26(4):1037-1058. PMID: 27757775
Background: Systemic corticosteroids (SCS) are commonly used but are associated with adverse effects. Given their prevalent use, the potential impact of SCS use on health-related quality of life (HRQoL) is...
10.
Sullivan P, Globe G, Ghushchyan V, Campbell J, Bender B, Magid D
Ann Allergy Asthma Immunol . 2016 Sep; 117(3):251-257.e2. PMID: 27613458
Background: Understanding the effect of worsening asthma control on expenditures and health resource utilization (HRU) is important. Objective: To explore the association of economic outcomes with asthma control cutoffs and...